Cargando…

Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343224/
https://www.ncbi.nlm.nih.gov/pubmed/34366793
http://dx.doi.org/10.3389/fncel.2021.728508
_version_ 1783734239524552704
collection PubMed
description
format Online
Article
Text
id pubmed-8343224
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83432242021-08-07 Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease Front Cell Neurosci Cellular Neuroscience Frontiers Media S.A. 2021-07-23 /pmc/articles/PMC8343224/ /pubmed/34366793 http://dx.doi.org/10.3389/fncel.2021.728508 Text en Copyright © 2021 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular Neuroscience
Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title_full Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title_fullStr Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title_full_unstemmed Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title_short Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease
title_sort retraction: resveratrol preincubation enhances the therapeutic efficacy of huc-mscs by improving cell migration and modulating neuroinflammation mediated by mapk signaling in a mouse model of alzheimer's disease
topic Cellular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343224/
https://www.ncbi.nlm.nih.gov/pubmed/34366793
http://dx.doi.org/10.3389/fncel.2021.728508
work_keys_str_mv AT retractionresveratrolpreincubationenhancesthetherapeuticefficacyofhucmscsbyimprovingcellmigrationandmodulatingneuroinflammationmediatedbymapksignalinginamousemodelofalzheimersdisease